The GDP Non-Compliance Reports of 2021 - An Overview
Register now for ECA's GMP Newsletter
Wholesale trade in medicinal products requires a wholesale authorisation. A certificate of Good Distribution Practice (GDP) is issued to a wholesale distributor by the national competent authority.
If the outcome of an inspection is that the wholesale Distributor does not comply with Good Distribution Practice, a statement of non-compliance may be entered into EudraGMDP. The EudraGMDP database is maintained and operated by the EMA.
Number of Reports
The number of GDP non-compliance reports entered into the EudraGMDP database in 2021 is – like the total number of reports – quite low. The following table gives an overview of the number of reports in recent years:
| Year | Number of GDP non-compliance reports |
| 2021 | 6 |
| 2020 | 6 |
| 2019 | 6 |
| 2018 | 4 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 0 |
| 2014 | 1 |
| Total | 25 |
Evaluation of the Reports entered in 2021
In 2021, the following reports were entered into the database (by clicking on the report number, you will get to a summary of the respective report):
| Report Number | Issue Date | Country |
| 24.05.01.17-03-0126 | 2021-12-03 | Germany |
| G3-6300.GH_Rowi-Med_20210816 | 2021-10-01 | Germany |
| sukls162731/2021 | 2021-08-06 | Czechia |
| NCD/011/RO | 2021-04-15 | Romania |
| 1 | 2021-03-05 | Germany |
| NCD/010/RO | 2021-01-22 | Romania |
The following table gives an overview of the deficiencies that led to issuing of the GDP non-compliance reports entered in 2021. The total number of deficiencies is greater than the number of reports, as in some cases several topics were listed:
| Area | Details | Quantity |
| Responsible Person (RP) | Doubtful reliability / No responsible person who possesses the required expert knowledge / RP does not properly perform his or her duties | 4 |
| Premises / storage | No suitable and adequate premises or storage areas, installations and facilities / Storage of expired medicinal products in between those ready for trading / Storage of expired medicinal products in regular stock | 4 |
| Procurement | Procuring from entities which are not authorized for wholesaling activities / Trading of medicinal products with unclear trade chain | 2 |
| Quality system | No GDP conform quality system | 1 |
| Change Management | No change control system | 1 |
| Deviations | Deviations were not documented | 1 |
| Self-Inspections | No self-inspections were performed | 1 |
| Training | Information on staff training could not be provided | 1 |
| Counterfeit medicines | Trading of falsified medicinal products | 1 |
| CEO | Doubtful reliability | 1 |
| Others | Missing connection to the securepharm-system / Company changed its address without information to or inspection of the competent authority | 2 |
Related GMP News
16.01.2025EMA adds Considerations for Wholesale Distributors and Brokers on suspicious Offers
16.01.2025Swissmed informs about Control Campaign against illegal Trading in Medicinal Products
16.01.2025Two new PICS Documents on Remote Assessments published
16.01.2025The GDP Non-Compliance Reports of 2024 - An Overview
17.12.2024GDP in the US: Pre-posting of USP Chapter <1079.2> on MKT
17.12.2024Romanian Authority Issues further GDP Non-Compliance Report